LLY vs MRK
Eli Lilly and Company vs Merck & Co. — AI-powered side-by-side comparison
| Metric | LLY | MRK |
|---|---|---|
| AI Score | 61 | 56 |
| Price | $1,216.24 | $125.97 |
| P/E Ratio | 45.75× | 35.46× |
| ROE | 101.3% | 17.9% |
| Revenue Growth YoY | 47.4% | 2.9% |
| Gross Margin | 82.8% | 78.1% |
| Debt / Equity | 1.60× | 0.94× |
| Dividend Yield | 0.6% | 2.6% |
| RSI (14) | 69.6 | 54.6 |
| Beta | 0.5016 | 0.2095 |
| Expected Upside | — | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
LLY Full Analysis
MRK Full Analysis